John Beigel

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. pmc Influenza
    John H Beigel
    National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, MD, USA
    Crit Care Med 36:2660-6. 2008
  2. pmc Current and future antiviral therapy of severe seasonal and avian influenza
    John Beigel
    National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    Antiviral Res 78:91-102. 2008
  3. pmc Safety and immunogenicity of multiple and higher doses of an inactivated influenza A/H5N1 vaccine
    John H Beigel
    National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Infect Dis 200:501-9. 2009
  4. pmc Safety and pharmacokinetics of single intravenous dose of MGAWN1, a novel monoclonal antibody to West Nile virus
    John H Beigel
    MacroGenics Inc, Rockville, MD, USA
    Antimicrob Agents Chemother 54:2431-6. 2010
  5. ncbi request reprint Avian influenza A (H5N1) infection in humans
    John H Beigel
    National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
    N Engl J Med 353:1374-85. 2005

Detail Information

Publications5

  1. pmc Influenza
    John H Beigel
    National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, MD, USA
    Crit Care Med 36:2660-6. 2008
    ..The objective of this review is to summarize current knowledge of influenza with emphasis on the issues that intensivist will encounter...
  2. pmc Current and future antiviral therapy of severe seasonal and avian influenza
    John Beigel
    National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    Antiviral Res 78:91-102. 2008
    ....
  3. pmc Safety and immunogenicity of multiple and higher doses of an inactivated influenza A/H5N1 vaccine
    John H Beigel
    National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Infect Dis 200:501-9. 2009
    ..We sought to generate high-titer H5N1 antibodies in healthy volunteers for the purpose of developing hyperimmune intravenous immunoglobulin...
  4. pmc Safety and pharmacokinetics of single intravenous dose of MGAWN1, a novel monoclonal antibody to West Nile virus
    John H Beigel
    MacroGenics Inc, Rockville, MD, USA
    Antimicrob Agents Chemother 54:2431-6. 2010
    ..Further evaluation of MGAWN1 for the treatment of West Nile virus infections is warranted...
  5. ncbi request reprint Avian influenza A (H5N1) infection in humans
    John H Beigel
    National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
    N Engl J Med 353:1374-85. 2005